Ocular Therapeutix
OCUL
#5024
Rank
HK$14.81 B
Marketcap
HK$67.67
Share price
0.52%
Change (1 day)
-25.36%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -HK$2.28 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are HK$52.03 Million. In 2025 the company made an earning of -HK$2.09 Billion a decrease over its 2024 earnings that were of -HK$1.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$2.28 Billion8.87%
2025 -HK$2.09 Billion37.43%
2024 -HK$1.52 Billion139.68%
2023 -HK$0.64 Billion13.65%
2022 -HK$0.56 Billion984.05%
2021 -HK$51.39 Million-95.79%
2020 -HK$1.23 Billion80.19%
2019 -HK$0.68 Billion44.01%
2018 -HK$0.48 Billion-5.38%
2017 -HK$0.5 Billion41.79%
2016 -HK$0.36 Billion12.47%
2015 -HK$0.32 Billion38.75%
2014 -HK$0.23 Billion115.12%
2013 -HK$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-HK$87.88 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-HK$96.09 Million-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-HK$1.27 Billion-44.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
HK$1.22 B-153.95%๐Ÿ‡บ๐Ÿ‡ธ USA